Cancer Immunology – Multimedia

This listicle highlights five commonly used cell viability assays and their benefits and limitations in immunotherapy potency testing.

Speaking at The Landscape of Cancer Research 2021 online symposium, Tianzi Li delivered her talk on the discovery of novel targets and the use of antibodies in cancer therapy.

The clinical success of CAR T-cell therapy has spurred increased interest and investments in the advanced therapeutics industry.

While CRISPR-edited cell lines can be beneficial for target identification, reagent validation, and biomarker discovery, generating high-quality cell lines can be fraught with difficulties and time-consuming and relies on several factors.

Speaking in June 2021 at the online symposium, Advances in Proteomics & Metabolomics, Dr. Genevieve Van de Bittner, R&D Researcher at Agilent Research Laboratories presented her talk on metabolic rate measurements using Seahorse XF and LC/MS technologies.

Download this eBook to learn more about the tools available for evaluating immune cell therapy potency.

Expansion of Specific Lymphocyte Populations With 4Cell® Nutri-T Xeno-Free, Serum-Free Medium

The success of CAR T-cell therapy requires efficient expansion of specific subpopulations of patient-derived immune cells.

Download this eBook to explore cancer epigenetic and genetic research, cell signaling in cancer, diagnosis and treatment developments, and immuno-oncology advances.

Lucy Lawrence will be speaking with Mark and hearing fascinating stories from throughout his career within the cancer immunology space, as well as asking more about targets that show particular promise and the greatest challenges in making them available.

In medicine, gene therapy is the process where nucleic acids are delivered to a patient’s cells as a therapeutic drug to treat an array of genetic diseases. All gene therapies utilize either viral or non-viral vectors to deliver the DNA or RNA into the host cell.